From: Pancreatic adenocarcinoma third line systemic treatments: a retrospective cohort study
Patients (%) (Total=251 patients) | |
---|---|
Gender | |
- Man | 130 (52%) |
- Woman | 121 (48%) |
Age | |
- a) under 50 | 43 (17%) |
- b) 50 to 70 | 174 (69%) |
- c) 70 or more | 34 (14%) |
Performance status at diagnosis | |
- 0 - 1 | 161 (96%) |
- 2 and more | 6 (4%) |
- Missing | 84 |
Disease stage at diagnosis | |
- Non Metastatic | 96 (38%) |
- Metastatic | 155 (62%) |
Liver metastasis | |
- No | 136 (54%) |
- Yes | 115 (46%) |
Regular alcohol intake | |
- No | 122 (72%) |
- Yes | 48 (28%) |
- Missing | 81 |
Smoking status | |
- No | 106 (61%) |
- Yes | 68 (39%) |
- Missing | 77 |
Associated thrombosis | |
- No | 83 (60%) |
- Yes | 55 (40%) |
- Missing | 113 |